109 related articles for article (PubMed ID: 8077053)
1. EBV infection of B-CLL cells in vitro potentiates their allostimulatory capacity if accompanied by acquisition of the activated phenotype.
Avila-Cariño J; Lewin N; Yamamoto K; Tomita Y; Mellstedt H; Brodin B; Rosén A; Klein E
Int J Cancer; 1994 Sep; 58(5):678-85. PubMed ID: 8077053
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.
Wendel-Hansen V; Sällström J; De Campos-Lima PO; Kjellström G; Sandlund A; Siegbahn A; Carlsson M; Nilsson K; Rosén A
Leukemia; 1994 Mar; 8(3):476-84. PubMed ID: 8127151
[TBL] [Abstract][Full Text] [Related]
3. B-CLL cells experimentally infected with EBV enter DNA synthesis, produce cytokines and stimulate T-lymphocytes.
Avila-Cariño J; Andersson J; Mellstedt H; Klein E
Immunol Lett; 1996 Dec; 54(1):45-52. PubMed ID: 9030981
[TBL] [Abstract][Full Text] [Related]
4. B-CLL cells with unusual properties.
Avila-Cariño J; Lewin N; Tomita Y; Szeles A; Sandlund A; Mosolits S; Mellstedt H; Klein G; Klein E
Int J Cancer; 1997 Jan; 70(1):1-8. PubMed ID: 8985083
[TBL] [Abstract][Full Text] [Related]
5. EBV infection of B-CLL cells in vitro potentiates their allostimulatory capacity if accompanied by acquisition of the activated phenotype.
Klein E; Avila-Cariño J
Curr Top Microbiol Immunol; 1995; 194():127-33. PubMed ID: 7895487
[No Abstract] [Full Text] [Related]
6. Recognition of B-CLL cells experimentally infected with EBV by autologous T lymphocytes.
Tomita Y; Avila-Cariño J; Yamamoto K; Mellstedt H; Klein E
Immunol Lett; 1998 Feb; 60(2-3):73-9. PubMed ID: 9580478
[TBL] [Abstract][Full Text] [Related]
7. Clonality and methylation status of the Epstein-Barr virus (EBV) genomes in in vivo-infected EBV-carrying chronic lymphocytic leukemia (CLL) cell lines.
Lewin N; Minarovits J; Weber G; Ehlin-Henriksson B; Wen T; Mellstedt H; Klein G; Klein E
Int J Cancer; 1991 Apr; 48(1):62-6. PubMed ID: 1850384
[TBL] [Abstract][Full Text] [Related]
8. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
Cuomo L; Trivedi P; de Campos-Lima PO; Zhang QJ; Ragnar E; Klein G; Masucci MG
Mol Immunol; 1993 Apr; 30(5):441-50. PubMed ID: 7681932
[TBL] [Abstract][Full Text] [Related]
9. Infection of leukaemic B lymphocytes by Epstein Barr virus.
Doyle MG; Catovsky D; Crawford DH
Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
[TBL] [Abstract][Full Text] [Related]
10. Cytokines and Epstein Barr virus (EBV) genes expression in blood chronic lymphocytic leukaemia (CLL) cells and their immortalised CLL cell lines.
Laytragoon-Lewin N; Chen F; Castro J; Avila-Carino J; Lewin F
Anticancer Res; 2003; 23(5A):4017-22. PubMed ID: 14666712
[TBL] [Abstract][Full Text] [Related]
11. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin 10 in B lymphocytes of different origin.
Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G
Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
[TBL] [Abstract][Full Text] [Related]
13. Activation and immortalization of leukaemic B cells by Epstein-Barr virus.
Walls EV; Doyle MG; Patel KK; Allday MJ; Catovsky D; Crawford DH
Int J Cancer; 1989 Nov; 44(5):846-53. PubMed ID: 2555307
[TBL] [Abstract][Full Text] [Related]
14. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
[TBL] [Abstract][Full Text] [Related]
15. The leukemic B-cell population of patients with monoclonal lymphocytosis of undetermined significance (MLUS) are functionally distinct from the chronic lymphocytic leukemia (CLL) derived cell population.
Aman P; Mellstedt H
Leuk Res; 1991; 15(8):715-9. PubMed ID: 1654482
[TBL] [Abstract][Full Text] [Related]
16. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes.
Rochford R; Hobbs MV; Garnier JL; Cooper NR; Cannon MJ
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):352-6. PubMed ID: 8380497
[TBL] [Abstract][Full Text] [Related]
18. MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.
Staege MS; Lee SP; Frisan T; Mautner J; Scholz S; Pajic A; Rickinson AB; Masucci MG; Polack A; Bornkamm GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4550-5. PubMed ID: 11917131
[TBL] [Abstract][Full Text] [Related]
19. The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.
Rasul E; Salamon D; Nagy N; Leveau B; Banati F; Szenthe K; Koroknai A; Minarovits J; Klein G; Klein E
PLoS One; 2014; 9(8):e106008. PubMed ID: 25162594
[TBL] [Abstract][Full Text] [Related]
20. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
Wilson AD; Morgan AJ
J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
